Ayşegül Ulu Kılıç

Ayşegül Ulu Kılıç

Auto-generated profile, based on publicly available information

Ayşegül Ulu Kılıç

Department of Infectious Diseases and Clinical Microbiology, Erciyes University Faculty of Medicine, Kayseri, Türkiye

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2018 in Turkish Journal of Intensive Care
Verified
Journal Article
Open access
ADAdem Dursun
Adem Dursun
SÖSerkan Özsoylu
Serkan Özsoylu
HKHüseyin Kılıç
Hüseyin Kılıç
AKAyşegül Ulu Kılıç
Ayşegül Ulu Kılıç
BABaşak Nur Akyıldız
Başak Nur Akyıldız
Amaç: Bu çalışmada kan ve endotrakeal aspirat örneklerinden izole edilen Pseudomonasa aeruginosa, Klebsiella pneumoniae ve Acinetobacter baumannii bakterilerinin antibiyotik duyarlılıklarının belirlenmesi ve uygun ampirik antibiyotik tedavisinin başlanması amaçlanmıştır. Gereç ve Yöntem: Erciyes Üniversitesi Tıp Fakültesi, Çocuk Yoğun Bakım Ünitesi’nden 1 Ocak 2013-30 Ağustos 2017 tarihleri arasında hastanemiz mikrobiyoloji laboratuvarına gönderilen ve Pseudomonas aeruginosa, Klebsiella pneumoniae ve Acinetobacter baumannii bakteri üremesi saptanan hastaların antibiyogram sonuçları retrospektif olarak değerlendirildi. Bulgular: Yaş ortancaları 17 ay (7-112) olan 65’i (%63,6) erkek, 56’sı (%36,4) kız toplam 111 hastadan gönderilen 135 örnek retrospektif olarak incelendi. Altmış sekiz örnekte Pseudomonas aeruginosa [kan: 31, endotrakealaspirat (ETA): 37], 42 örnekte Acinetobacter baumannii (kan: 22, ETA: 20), 25 örnekte ise Klebsiella pneumoniae (kan: 18, ETA: 7) üremesi tespit edildi. Amikasin direnç oranı en düşük antibiyotik olarak görülürken (%23,7), sefepim, seftazidim, meropenem, siprofloksasin ve gentamisin direnç oranları sırasıyla %49,6, %53,7, %62,2, %46,7 ve %60 olarak saptandı. Amikasin direnci Pseudomonas aeruginosa, Acinetobacter baumannii ve Klebsiella pneumoniae için sırasıyla %5,9, %64,3 ve %4 olarak tespit edilmiştir. Sonuç: Çalışmamız yoğun bakım ünitelerinde Acinetobacter, Pseudomonas ve Klebsiella için ciddi karbapenem direnci saptanması nedeniyle bu ilacı kullanmaya karar verirken daha dikkatli olunması gerektiğini düşündürmektedir. Ayrıca amikasinin ampirik tedavide iyi bir seçenek olduğunu göstermektedir.

1 December 2020 in Hamidiye Medical Journal
Verified
Journal Article
Closed access
ATAyşin Kılınç Toker
Ayşin Kılınç Toker
AKAyşegul Ulu Kılıç
Ayşegul Ulu Kılıç
EEEsma Eryilmaz-Eren
Esma Eryilmaz-Eren
ZDZehra Beştepe Dursun
Zehra Beştepe Dursun
ITIbrahim Toker
Ibrahim Toker
IÇIlhami Çelik
Ilhami Çelik

1 January 2020 in Infection & Chemotherapy
Verified
Journal Article
Open access
PDF file
EEEsma Eryilmaz-Eren
Esma Eryilmaz-Eren
Emine ALP MEŞEEmine ALP MEŞE
Emine ALP MEŞE
FCFatma Cevahir
Fatma Cevahir
TTTuğba Tok
Tuğba Tok
AKAyşegül Ulu Kılıç
Ayşegül Ulu Kılıç
RYRecep Civan Yuksel
Recep Civan Yuksel
Eren E, et al. Infect Chemother. 2020 Dec;52(4):530-538. https://doi.org/10.3947/ic.2020.52.4.530

30 April 2021 in Klimik Dergisi/Klimik Journal
Verified
Journal Article
Closed access
EEEsma Eryilmaz-Eren
Esma Eryilmaz-Eren
AUAyşegül Ulu-Kılıç
Ayşegül Ulu-Kılıç
Zeynep ... TureZeynep ... Ture
Zeynep ... Ture
FCFatma Cevahir
Fatma Cevahir
HKHüseyin Kılıç
Hüseyin Kılıç
Emine ALP MEŞEEmine ALP MEŞE
Emine ALP MEŞE
Objective: Carbapenem-resistant Klebsiella pneumoniae (CRKp) is among the leading causes of hospital-acquired infections worldwide and causes serious and life-threatening infections. Treatment options are very limited for blood stream infections (BSIs) and prognosis is poor due to increasing multi-drug resistance. The aim of this study was to assess risk factors for the mortality due to CRKp-BSI. Methods: A retrospective study was conducted in a university hospital from September 2013 to October 2017. Patients (aged >16 years) with CRKp-BSI were included in this study. Data, including demographics, Charlson comorbidity index (CCI), acute physiology and chronic health evaluation II (APACHE II) score on hospitalisation date, minimum inhibitory concentration (MIC) of CRKp, antibiotic treatment and outcome (30-day mortality) data were collected from the electronic medical records and microbiology databases. Results: A total of 82 patients with CRKP-BSIs were analysed. The median age was 54.5 years, and 48 (58.5%) of them were male. The median APACHE II score on hospitalisation was 14 (IQR 6-28) and CCI was 4.0 (IQR 0-12). Forty-six (56.1%) patients had ICU-acquired bacteremia and 36 (43.9%) had central-line associated bacteremia and 25 (30.5%) had primary bacteremia. Fifty (61.0%) patients had combination therapy, colistin/tigecycline (28%) was the most used antibiotic combination. The mortality of all patients was 56.1% (46/82) and 65.2% (30/46) in ICU patients. In univariate analysis, risk factors for the mortality of CRKp-BSI were high CCI, not having clinical response on the fifth day of treatment, high APACHE II score on hospitalisation and infection date and multiple organ dysfunction syndrome. In multivariate analysis, the most significant risk factor for mortality was APACHE II score on infection day (OR: 1.190; 95% CI: 1.088-1.301). Treatment regimens and combination therapy vs. monotherapy were not found to be significantly associated with survival. In addition, MIC values of CRKp were not associated with mortality. Conclusions: Patients with CRKp-BSI had high mortality (56.1%). APACHE II score on infection day was significantly associated with mortality. The outcome was similar between patients receiving combination (54.3%) or monotherapy (45.7%).

29 June 2022 in Flora the Journal of Infectious Diseases and Clinical Microbiology
Verified
Journal Article
Closed access
GUGamze Kalın Unuvar
Gamze Kalın Unuvar
Zeynep ... TureZeynep ... Ture
Zeynep ... Ture
AKAyşegül Ulu Kılıç
Ayşegül Ulu Kılıç
MKMuzaffer Keklik
Muzaffer Keklik
FCFatma Cevahir
Fatma Cevahir

12 March 2026 in American Journal of Infection Control
Verified
Journal Article
Closed access
Zeynep ... TureZeynep ... Ture
Zeynep ... Ture
GBGülseren Maraş Baydoğan
Gülseren Maraş Baydoğan
FÇFeyza İzCi Çetinkaya
Feyza İzCi Çetinkaya
MTMüslüm Tarkan
Müslüm Tarkan
EEEsma Eryilmaz-Eren
Esma Eryilmaz-Eren
AKAyşegül Ulu Kılıç
Ayşegül Ulu Kılıç